Hoth Therapeutics Inc Ordinary Shares HOTH
News
Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial
Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Hoth Therapeutics Expands Clinical Trial for Cancer Patients
Hoth Therapeutics Shares Rise 14% After FDA Clearance for HT-001 Trial Amendments